On the other hand, ginsenoside Re effectively enhanced the expression of ChAT and vesicular acetylcholine transporter (VAChT) in N2a cells, which in turn increased the production of ACh, thereby affecting the AD development process [179]. The gene discussed is CHAT; the disease is Alzheimer disease.